0001178913-22-004049.txt : 20221115
0001178913-22-004049.hdr.sgml : 20221115
20221115160338
ACCESSION NUMBER: 0001178913-22-004049
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221114
FILED AS OF DATE: 20221115
DATE AS OF CHANGE: 20221115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Frankel Matthew Bejosa
CENTRAL INDEX KEY: 0001952634
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38807
FILM NUMBER: 221391150
MAIL ADDRESS:
STREET 1: 672 PROSPECT AVE.
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Chemomab Therapeutics Ltd.
CENTRAL INDEX KEY: 0001534248
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813676773
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: KIRYAT ATIDIM, BUILDING 7
CITY: TEL AVIV
STATE: L3
ZIP: 6158002
BUSINESS PHONE: 972-77-331-0156
MAIL ADDRESS:
STREET 1: KIRYAT ATIDIM, BUILDING 7
CITY: TEL AVIV
STATE: L3
ZIP: 6158002
FORMER COMPANY:
FORMER CONFORMED NAME: Anchiano Therapeutics Ltd.
DATE OF NAME CHANGE: 20180906
FORMER COMPANY:
FORMER CONFORMED NAME: BioCancell Ltd.
DATE OF NAME CHANGE: 20111104
3
1
ownership.xml
X0206
3
2022-11-14
0
0001534248
Chemomab Therapeutics Ltd.
CMMB
0001952634
Frankel Matthew Bejosa
C/O CHEMOMAB THERAPEUTICS LTD.,
672 PROSPECT AVE.
PRINCETON
NJ
08540
0
1
0
0
Chief Medical Officer
Options to Purchase American Depositary Shares
2.07
2032-11-14
American Depositary Shares
125000
D
Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
25% of these options will vest and become exercisable on the first anniversary of November 14, 2022, and the remaining 75% of these options will vest in equal amounts over a 36-month period commencing on November 14, 2023, subject to the Reporting Person's continued service.
/s/ Matthew B. Frankel
2022-11-15